2024-07-25 14:27:06 ET
Chemed Corporation (CHE)
Q2 2024 Earnings Conference Call
July 25, 2024 10:00 AM ET
Company Participants
Holley Schmidt - Assistant Controller
Kevin McNamara - President & Chief Executive Officer
Mike Witzeman - Chief Financial Officer
Nick Westfall - Chairman & Chief Executive Officer, VITAS Healthcare Corporation
Conference Call Participants
Ben Hendrix - RBC Capital Markets
Joanna Gajuk - Bank of America
Presentation
Operator
Thank you for standing by and welcome to the Chemed Corporation Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. [Operator Instructions]. As a reminder, today's program is being recorded.
And now I'd like to introduce your host for today's program, Holley Schmidt. Please go ahead, ma'am.
Holley Schmidt
Good morning. Our conference call this morning will review the financial results for the second quarter of 2024 ended June 30th, 2024. Before we begin, let me remind you that the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995 apply to this conference call.
During the course of this call, the company will make various remarks concerning management's expectations, predictions, plans, and prospects that constitute forward-looking statements. Actual results may differ materially from those projected by these forward-looking statements as a result of a variety of factors, including those identified in the company's news release of July 24th and in various other filings with the SEC....
Read the full article on Seeking Alpha
For further details see:
Chemed Corporation (CHE) Q2 2024 Earnings Call Transcript